« The use of probiotics is an essential component in the treatment of intestinal pathologies associated with autism. However, the number and type of strains, dosage and duration are critical factors which are often overlooked due to a lack of proper information. » — Senta Depuydt
There is a growing interest from researchers to find new options in the treatment of digestive disorders (dysbiosis), which is one of the most common conditions that affects young autistic patients. I enthusiastically accepted the invitation of Senta Depuydt, who is leading the conference ‘Sortir de l’Autisme’ and participated in a discussion with parents and researchers in the field, on June 29, 2016 from 19 to 20.00 pm.
As a pioneer in the field of intestinal microflora with international recognition, I was one of the first researchers to develop a high-dose probiotic preparation containing 8 strains, 450 billion bacteria (Vivomixx®). This is one of the few probiotics presenting over 170 scientific publications and which has been included in the international treatment guidelines for certain indications.
I have a specific interest in autism, and many people will be interested to know that in Italy, with the help of the Ministry of Health, a study on the use of probiotics in autistic children has just started, as I have already discussed in this blog Clinical study: impact of probiotics in autistic children
To register :
You can also ask questions ahead of the webinar: